Real Peptides KLOW Blend

Description

KLOW Blend is a multi-component research formulation combining four peptides frequently studied together in preclinical tissue-repair and anti-inflammatory models: BPC-157, a pentadecapeptide investigated for cytoprotective and angiogenic activity; TB-500, a fragment of thymosin beta-4 studied for actin regulation and cell migration; GHK-Cu, a copper-binding tripeptide examined for extracellular matrix remodeling; and KPV, an alpha-MSH-derived tripeptide studied for anti-inflammatory signaling. It is provided as a combined tool preparation for investigating their interacting endpoints in experimental designs.

KLOW Blend has been examined in preclinical in vitro and rodent model studies of angiogenesis, extracellular matrix synthesis, cell migration, inflammatory cytokine and NF-kB signaling, and wound-healing dynamics. Its combined formulation supports comparative and additive-effect research across the tissue-repair and anti-inflammatory pathways associated with its constituent peptides in cell-based and rodent models.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.